Guizhou Chitianhua Co.,Ltd.'s (SHSE:600227) Market Cap Dropped CN¥457m Last Week; Retail Investors Bore the Brunt
Key Insights The considerable ownership by retail investors in Guizhou ChitianhuaLtd indicates that they collectively have a greater say in management and business strategy 42% of the business is he
ChiTianhua (600227.SH) involved two lawsuits relating to coal purchase contracts
Chitianhua (600227.SH) issued an announcement. On May 29, 2024, the company received a notice located in Zunyi, Guizhou Province...
Chitianhua (600227.SH): Total cost of 15.08 million yuan to repurchase 0.4539% of the joint stock company completed the repurchase
Gelonghui, May 20, 丨 Chitianhua (600227.SH) announced that on May 17, 2024, the company completed the repurchase and actually repurchased 7,685,700 shares of the company's shares, accounting for 0.4539% of the company's total share capital. The highest repurchase price was 2.15 yuan/share, the lowest repurchase price was 1.74 yuan/share, the average repurchase price was 1.95 yuan/share, and the total capital used was 15,008,379 yuan (excluding transaction fees).
Chitianhua (600227.SH): A total of 2,921,000 shares have been repurchased
Gelonghui, May 6, 丨 Chitianhua (600227.SH) announced that as of April 30, 2024, the company had repurchased 2,921,100 shares, accounting for 0.1725% of the company's total share capital. The highest purchase price was 2.10 yuan/share, the lowest price was 1.74 yuan/share, and the total amount paid was 5,454,740 yuan.
ChiTianhua (600227.SH) announced first-quarter results with a net loss of 40.1807 million yuan
ChiTianhua (600227.SH) released its report for the first quarter of 2024. The company's revenue was 437 million yuan,...
Guizhou ChitianhuaLtd (SHSE:600227 Shareholders Incur Further Losses as Stock Declines 13% This Week, Taking Five-year Losses to 55%
Generally speaking long term investing is the way to go. But no-one is immune from buying too high. To wit, the Guizhou Chitianhua Co.,Ltd. (SHSE:600227) share price managed to fall 55% over five lo
Chatianhua (600227.SH): A total of 599,500 shares have been repurchased
Gelonghui, April 1, 丨 Chitianhua (600227.SH) announced that as of March 31, 2024, the company had repurchased a total of 599,500 shares, accounting for 0.035% of the company's total share capital. The highest purchase price was 2.10 yuan/share, the lowest price was 2.05 yuan/share, and the total amount paid was 1,249,395.00 yuan.
Chatianhua (600227.SH): Initial repurchase of 599,500 shares
Gelonghui, March 26, 丨 Chitianhua (600227.SH) announced that on March 26, 2024, the company repurchased 599,500 shares for the first time through centralized bidding. The repurchased shares accounted for 0.035% of the company's total share capital. The highest purchase price was 2.10 yuan/share, the lowest price was 2.05 yuan/share, and the total amount paid was 1,249,395.00 yuan.
Subdued Growth No Barrier To Guizhou Chitianhua Co.,Ltd. (SHSE:600227) With Shares Advancing 28%
Guizhou Chitianhua Co.,Ltd. (SHSE:600227) shareholders are no doubt pleased to see that the share price has bounced 28% in the last month, although it is still struggling to make up recently lost grou
Chitianhua (600227.SH): Plans to spend 15 million yuan to 30 million yuan to buy back shares
Gelonghui, Feb. 18 | Chitianhua (600227.SH) announced that the purpose of the company's current share repurchase is necessary to protect the company's value and shareholders' rights. The repurchased shares will be used for sale in accordance with relevant regulations, and the overdue portion of the sale will be cancelled after complying with the relevant regulatory requirements and procedures stipulated in the company's articles of association. The total capital for repurchasing shares shall not be less than RMB 15 million (inclusive) and not more than RMB 30 million (inclusive).
Chitianhua (600227.SH): Chairman Ding Linhong proposes to buy back 15 million yuan to 30 million yuan of shares
Gelonghui, Feb. 7: Chitianhua (600227.SH) announced that the company received a “Letter on Proposal to Repurchase the Company's Shares” from Mr. Ding Linhong, Chairman of the Company. Mr. Ding Linhong proposed that the company use its own funds to buy back some of the RMB common stock (A shares) shares already issued by the company through centralized bidding transactions through the Shanghai Stock Exchange trading system. The total capital for the repurchase of shares this time is not less than RMB 15 million and no more than RMB 30 million.
Some Guizhou Chitianhua Co.,Ltd. (SHSE:600227) Shareholders Look For Exit As Shares Take 27% Pounding
Guizhou Chitianhua Co.,Ltd. (SHSE:600227) shareholders that were waiting for something to happen have been dealt a blow with a 27% share price drop in the last month. Instead of being rewarded, sha
Chitianhua (600227.SH): Pre-loss of 100 million yuan to 150 million yuan in 2023
Gelonghui, January 30, 丨 Chitianhua (600227.SH) announced the 2023 annual results pre-loss announcement. According to preliminary estimates by the finance department, it is expected to achieve net profit attributable to the owner of the parent company in 2023 - 10,000 yuan to -150 million yuan. Compared with the same period last year (legally disclosed data), there will be continuous losses. It is expected to achieve net profit of 260 million yuan to -330 million yuan after deducting non-recurring profit and loss due to the owners of the parent company in 2023.
We Think Guizhou ChitianhuaLtd (SHSE:600227) Has A Fair Chunk Of Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
ChiTianhua (600227.SH) released the first three quarter results, with a net loss of 246 million yuan
Chi Tianhua (600227.SH) disclosed its report for the third quarter of 2023. The company achieved revenue of 16 in the first three quarters...
Investors Are Selling off Guizhou ChitianhuaLtd (SHSE:600227), Lack of Profits No Doubt Contribute to Shareholders One-year Loss
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When you buy individual stocks, you can make higher profits, but you also face the risk o
Guizhou Salvage Pharma Suspends Methanol Production
Guizhou Salvage Pharmaceutical (SHA:600227) has suspended production of methanol at a factory operated by its wholly owned subsidiary Tongzi Chemical, according to a filing on Thursday. The subsidiary
ChiTianhua (600227.SH): Wholly-owned subsidiary Tongzi Chemical's methanol plant suspends production
Glonghui, October 18丨ChiTianhua (600227.SH) announced that Guizhou Chitianhua Tongzi Chemical Co., Ltd., a wholly-owned subsidiary of the company, is a large-scale coal chemical enterprise using coal as the main production raw material. It mainly produces urea and methanol products, with an annual production capacity of 520,000 tons of urea and 300,000 tons of methanol. Based on the company's current coal price and methanol sales price estimates, combined with future coal and methanol price trends, Tongzi Chemical's methanol plant is currently not economical to operate. Following a special study by the company's general manager's office, it was decided to suspend production of the Tongzi Chemical methanol plant on October 18, 2023. Subsequent companies will be based on
Guizhou Salvage Pharma to Absorb Daqin Hospital From Subsidiary
Guizhou Salvage Pharmaceutical (SHA:600227) plans to absorb Guizhou Daqin Oncology Hospital from its own subsidiary, Guizhou Shengjitang Pharmaceutical, according to a filing on Monday. Daqin Hospital
Akatianization (600227.SH): Proposed asset replacement
Glonghui September 10: ChiTianhua (600227.SH) announced that in order to focus on the company's chemical business, reduce related transactions, guarantee the supply of raw materials for the chemical business, and reduce the procurement and transportation costs of coal, the company plans to establish a new subsidiary to acquire the Huaqiu Second Mine mining rights and related ancillary assets held by Huaqiu Mining. At the same time, since the pharmaceutical business of listed companies is affected by national policies and other factors, the pharmaceutical sector is facing losses. In order to enhance the profitability of listed companies, it is proposed to invest shares in Shengjitang Pharmaceutical and all of its subsidiaries other than Daqin Hospital to Huaqiu Mining (Shengjitang Pharmaceutical's subsidiaries other than Daqin Hospital, with the exception of Daqin Hospital,
No Data